Cargando…

The Clinical Features of Cystic Parathyroid Adenoma in Chinese Population: A Single-Center Experience

OBJECTIVE: Cystic parathyroid adenoma is a rare cause of primary hyperparathyroidism, but its preoperative diagnosis and management remain inconclusive. METHOD: We retrospectively identified patients with cystic parathyroid adenomas who underwent surgery at Peking Union Medical College Hospital. RES...

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, Ya, Cui, Ming, Xia, Yu, Su, Zhe, Zhang, Xiang, Liao, Quan, Jiang, Yuxin, Zhao, Yupei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6079486/
https://www.ncbi.nlm.nih.gov/pubmed/30123260
http://dx.doi.org/10.1155/2018/3745239
_version_ 1783345286626672640
author Hu, Ya
Cui, Ming
Xia, Yu
Su, Zhe
Zhang, Xiang
Liao, Quan
Jiang, Yuxin
Zhao, Yupei
author_facet Hu, Ya
Cui, Ming
Xia, Yu
Su, Zhe
Zhang, Xiang
Liao, Quan
Jiang, Yuxin
Zhao, Yupei
author_sort Hu, Ya
collection PubMed
description OBJECTIVE: Cystic parathyroid adenoma is a rare cause of primary hyperparathyroidism, but its preoperative diagnosis and management remain inconclusive. METHOD: We retrospectively identified patients with cystic parathyroid adenomas who underwent surgery at Peking Union Medical College Hospital. RESULTS: Patients with cystic parathyroid adenomas had higher serum intact parathyroid hormone and calcium levels, larger maximum tumor diameter, and lower serum inorganic phosphorus level than did those with solid adenomas. Patients with cystic adenomas were predominantly male, and hypercalcemic crisis and atypical adenomas were common. The accuracy of preoperative localization methodologies was lower in patients with cystic adenomas than in patients with solid adenomas. US-guided fine-needle aspiration was performed in 11 patients. In all patients, the iPTH level in cystic fluid was much higher than that in serum. No sign of recurrence was observed after a median follow-up of 39 months. CONCLUSIONS: Cystic parathyroid adenomas may not be as rare as previously reported. FNA may be a safe and feasible localization methodology for patients with inconclusive preoperative localization methodologies. Close follow-up is necessary for patients with cystic parathyroid adenomas, which account for a substantial proportion of atypical adenoma cases.
format Online
Article
Text
id pubmed-6079486
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-60794862018-08-19 The Clinical Features of Cystic Parathyroid Adenoma in Chinese Population: A Single-Center Experience Hu, Ya Cui, Ming Xia, Yu Su, Zhe Zhang, Xiang Liao, Quan Jiang, Yuxin Zhao, Yupei Int J Endocrinol Research Article OBJECTIVE: Cystic parathyroid adenoma is a rare cause of primary hyperparathyroidism, but its preoperative diagnosis and management remain inconclusive. METHOD: We retrospectively identified patients with cystic parathyroid adenomas who underwent surgery at Peking Union Medical College Hospital. RESULTS: Patients with cystic parathyroid adenomas had higher serum intact parathyroid hormone and calcium levels, larger maximum tumor diameter, and lower serum inorganic phosphorus level than did those with solid adenomas. Patients with cystic adenomas were predominantly male, and hypercalcemic crisis and atypical adenomas were common. The accuracy of preoperative localization methodologies was lower in patients with cystic adenomas than in patients with solid adenomas. US-guided fine-needle aspiration was performed in 11 patients. In all patients, the iPTH level in cystic fluid was much higher than that in serum. No sign of recurrence was observed after a median follow-up of 39 months. CONCLUSIONS: Cystic parathyroid adenomas may not be as rare as previously reported. FNA may be a safe and feasible localization methodology for patients with inconclusive preoperative localization methodologies. Close follow-up is necessary for patients with cystic parathyroid adenomas, which account for a substantial proportion of atypical adenoma cases. Hindawi 2018-07-15 /pmc/articles/PMC6079486/ /pubmed/30123260 http://dx.doi.org/10.1155/2018/3745239 Text en Copyright © 2018 Ya Hu et al. http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Hu, Ya
Cui, Ming
Xia, Yu
Su, Zhe
Zhang, Xiang
Liao, Quan
Jiang, Yuxin
Zhao, Yupei
The Clinical Features of Cystic Parathyroid Adenoma in Chinese Population: A Single-Center Experience
title The Clinical Features of Cystic Parathyroid Adenoma in Chinese Population: A Single-Center Experience
title_full The Clinical Features of Cystic Parathyroid Adenoma in Chinese Population: A Single-Center Experience
title_fullStr The Clinical Features of Cystic Parathyroid Adenoma in Chinese Population: A Single-Center Experience
title_full_unstemmed The Clinical Features of Cystic Parathyroid Adenoma in Chinese Population: A Single-Center Experience
title_short The Clinical Features of Cystic Parathyroid Adenoma in Chinese Population: A Single-Center Experience
title_sort clinical features of cystic parathyroid adenoma in chinese population: a single-center experience
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6079486/
https://www.ncbi.nlm.nih.gov/pubmed/30123260
http://dx.doi.org/10.1155/2018/3745239
work_keys_str_mv AT huya theclinicalfeaturesofcysticparathyroidadenomainchinesepopulationasinglecenterexperience
AT cuiming theclinicalfeaturesofcysticparathyroidadenomainchinesepopulationasinglecenterexperience
AT xiayu theclinicalfeaturesofcysticparathyroidadenomainchinesepopulationasinglecenterexperience
AT suzhe theclinicalfeaturesofcysticparathyroidadenomainchinesepopulationasinglecenterexperience
AT zhangxiang theclinicalfeaturesofcysticparathyroidadenomainchinesepopulationasinglecenterexperience
AT liaoquan theclinicalfeaturesofcysticparathyroidadenomainchinesepopulationasinglecenterexperience
AT jiangyuxin theclinicalfeaturesofcysticparathyroidadenomainchinesepopulationasinglecenterexperience
AT zhaoyupei theclinicalfeaturesofcysticparathyroidadenomainchinesepopulationasinglecenterexperience
AT huya clinicalfeaturesofcysticparathyroidadenomainchinesepopulationasinglecenterexperience
AT cuiming clinicalfeaturesofcysticparathyroidadenomainchinesepopulationasinglecenterexperience
AT xiayu clinicalfeaturesofcysticparathyroidadenomainchinesepopulationasinglecenterexperience
AT suzhe clinicalfeaturesofcysticparathyroidadenomainchinesepopulationasinglecenterexperience
AT zhangxiang clinicalfeaturesofcysticparathyroidadenomainchinesepopulationasinglecenterexperience
AT liaoquan clinicalfeaturesofcysticparathyroidadenomainchinesepopulationasinglecenterexperience
AT jiangyuxin clinicalfeaturesofcysticparathyroidadenomainchinesepopulationasinglecenterexperience
AT zhaoyupei clinicalfeaturesofcysticparathyroidadenomainchinesepopulationasinglecenterexperience